C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/96 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61P 19/00 (2006.01) A61P 25/00 (2006.01) C07D 241/04 (2006.01) C07D 241/08 (2006.01)
Patent
CA 2315481
This invention relates to a method of treatment for osteoarthritis involving inhibitors of aggrecanase that demonstrate IC50S of less than 20 nM and demonstrate differential potency against matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs or reprolysins). This invention also relates to compounds, methods of treatment and composition of Formula I: (see formula I) or a therapeutically acceptable salt thereof, wherein X is carbon or nitrogen; R1 and R2 are independently selected from the group consisting of hydrogen, hydroxy, and methyl, wherein at least one of R1 and R2 is methyl; R3 and R4 are independently selected from the group consisting of hydrogen, hydroxy, and methyl, or R3 and R4 may be taken together to form a carbonyl group; and R5 and R6 are independent substituents in the ortho, meta, or para positions and are independently selected from the group consisting of hydrogen, halogen, cyano, methyl, and ethyl; with the provisos: when X is carbon, then R7 and R8 are both hydrogen and at least one of R1, R2, R3, and R4 is hydroxy; when X is carbon and R5 is para-halo, then at least one of R6, R3, and R4 is not hydrogen; when X is nitrogen, then R8 is not present and R7 is hydrogen or a group of the formula: Image wherein, Y is -CH2-NH2 or -NH-CH3; and when X is nitrogen and R7 is H, then R3 and R4 are taken together to form a carbonyl group.
Hawkins Joel Michael
Letavic Michael Anthony
Noe Mark Carl
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Selective inhibition of aggrecanase in osteoarthritis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective inhibition of aggrecanase in osteoarthritis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective inhibition of aggrecanase in osteoarthritis treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1571972